1. TLT-1 Promotes Platelet–Monocyte Aggregate Formation to Induce IL-10–Producing B Cells in Tuberculosis
- Author
-
Manni Wang, Xingyu Li, Qiaohua Wang, Mei Zhang, Jianzhong He, Siqi Ming, Ziqing Wang, Can Cao, Shunxian Zhang, Lanlan Geng, Sitang Gong, Xi Huang, Kang Chen, and Yongjian Wu
- Subjects
Blood Platelets ,CD40 Ligand ,Immunology ,Humans ,Tuberculosis ,Immunology and Allergy ,Receptors, Immunologic ,Monocytes ,Interleukin-10 - Abstract
The immunoregulation of platelets and platelet–monocyte aggregates (PMAs) is increasingly recognized, but it roles in tuberculosis (TB) remain to be elucidated. In this study, we found that CD14+CD41+ PMAs were increased in peripheral blood of patients with active TB. CD14+CD41+ PMAs highly expressed triggering receptors expressed on myeloid cells (TREMs)-like transcript-1 (TLT-1), P-selectin (CD62P), and CD40L. Our in vitro study found that platelets from patients with active TB aggregate with monocytes to induce IL-1β and IL-6 production by monocytes. Importantly, we identified that TLT-1 was required for formation of PMAs. The potential TLT-1 ligand was expressed and increased on CD14+ monocytes of patients with TB determined by using TLT-1 fusion protein (TLT-1 Fc). Blocking of ligand–TLT-1 interaction with TLT-1 Fc reduced PMA formation and IL-1β and IL-6 production by monocytes. Further results demonstrated that PMAs induced IL-10 production by B cells (B10) dependent on IL-1β, IL-6, and CD40L signals in a coculture system. Moreover, TLT-1 Fc treatment suppressed B10 polarization via blocking PMA formation. Taking all of these data together, we elucidated that TLT-1 promoted PMA-mediated B10 polarization through enhancing IL-1β, IL-6, and CD40L origin from PMAs, which may provide potential targeting strategies for TB disease treatment.
- Published
- 2022
- Full Text
- View/download PDF